Cameron’s Law
Bill journey · stage 2 of 5
Under committee review
What it doesSummary introduced in house (Apr 16, 2021)
Cameron's Law
This bill increases the rate of the tax credit for clinical testing expenses for rare diseases or conditions from 25% to 50% (orphan drug tax credit).
The bill also requires the Centers for Disease Control and Prevention to complete a study to evaluate the feasibility of enhancing and expanding the infrastructure to track the epidemiology of rare diseases or conditions.
What just happenedApr 19, 2021
Referred to the Subcommittee on Health.
Who’s behind it
- Introduced in HouseApr 16, 2021
- Apr 19, 2021Committee
Referred to the Subcommittee on Health.
Health Subcommittee - Apr 16, 2021IntroReferralH11100
Referred to the Committee on Ways and Means, and in addition to the Committee on Energy and Commerce, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Energy and Commerce Committee - Apr 16, 2021IntroReferralH11100
Referred to the Committee on Ways and Means, and in addition to the Committee on Energy and Commerce, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Ways and Means Committee - Apr 16, 2021IntroReferralIntro-H
Introduced in House
- Apr 16, 2021IntroReferral1000
Introduced in House